Answer
Fluconazole, a strong CYP2C9 inhibitor, may increase systemic lacosamide exposure, so concomitant treatment requires caution; this potential interaction is based on in vitro data and has not been established in vivo.
Sources for this answer
- Vimpat 50mg film-coated tabletsUCB Pharma Limited · emc · SmPC §4.5 Interaction with other medicinal products · Version 15Document updated
Sources checked